Marriott Tina
SEC CIK 1856414 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Pres, COO | 506.9K | — | $1.89M | 72 | 2021-11-18 | 2024-11-15 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Marriott Tina made no open-market trades at RXRX in the last 12 months.
Transactions 72
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | F - Tax | $6.18 | -14.3K | 506.9K | -3% | -$88.3K | |
| D | 2024-10-28 | 2024-10-24 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $6.31 | -6,000 | 521.1K | -1% | -$37.9K |
| D | 2024-10-28 | 2024-10-24 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +6,000 | 527.1K | +1% | +$6,360 |
| D | 2024-09-30 | 2024-09-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $7.00 | -6,000 | 521.1K | -1% | -$42.0K |
| D | 2024-09-30 | 2024-09-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +6,000 | 527.1K | +1% | +$6,360 |
| D | 2024-09-03 | 2024-08-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +6,000 | 527.1K | +1% | +$6,360 |
| D | 2024-09-03 | 2024-08-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $7.56 | -6,000 | 521.1K | -1% | -$45.4K |
| 2024-08-19 | 2024-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | F - Tax | $6.69 | -14.3K | 521.1K | -3% | -$95.8K | |
| D | 2024-07-29 | 2024-07-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +6,000 | 541.5K | +1% | +$6,360 |
| D | 2024-07-29 | 2024-07-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $8.13 | -6,000 | 535.5K | -1% | -$48.8K |
| D | 2024-06-28 | 2024-06-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +6,000 | 541.5K | +1% | +$6,360 |
| D | 2024-06-28 | 2024-06-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $7.22 | -6,000 | 535.5K | -1% | -$43.3K |
| D | 2024-06-03 | 2024-05-30 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +3,000 | 538.5K | +0.6% | +$3,180 |
| D | 2024-06-03 | 2024-05-30 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $8.78 | -3,000 | 535.5K | -0.6% | -$26.3K |
| 2024-05-17 | 2024-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | F - Tax | $10.01 | -9,998 | 533.2K | -2% | -$100.1K | |
| D | 2024-04-29 | 2024-04-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $7.67 | -3,000 | 543.2K | -0.5% | -$23.0K |
| D | 2024-04-29 | 2024-04-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +3,000 | 546.2K | +0.6% | +$3,180 |
| D | 2024-03-25 | 2024-03-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +8,000 | 648.0K | +1% | +$8,480 |
| DM | 2024-03-25 | 2024-03-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $10.75 | -8,000 | 640.6K | -1% | -$86.0K |
| D | 2024-02-23 | 2024-02-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +8,000 | 648.0K | +1% | +$8,480 |
| D | 2024-02-23 | 2024-02-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | S - Sale+OE | $14.90 | -8,000 | 640.0K | -1% | -$119.2K |
| 2024-02-16 | 2024-02-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | F - Tax | $12.43 | -5,379 | 640.0K | -0.8% | -$66.9K | |
| D | 2024-02-13 | 2024-02-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | F - Tax | $10.09 | -2,800 | 645.4K | -0.4% | -$28.3K |
| DM | 2024-02-13 | 2024-02-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Marriott Tina | Pres, COO | A - Grant | $0.00 | +233.6K | 424.2K | +123% | $0 |
| D | 2024-01-29 | 2024-01-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 422.6K | +2% | +$8,480 |
| D | 2024-01-29 | 2024-01-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.35 | -8,000 | 414.5K | -2% | -$82.8K |
| D | 2024-01-02 | 2023-12-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.58 | -8,000 | 414.5K | -2% | -$84.6K |
| D | 2024-01-02 | 2023-12-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 422.5K | +2% | +$8,480 |
| D | 2023-11-17 | 2023-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $7.18 | -5,378 | 413.4K | -1% | -$38.6K |
| D | 2023-11-17 | 2023-11-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $6.76 | -3,000 | 413.4K | -0.7% | -$20.3K |
| D | 2023-11-17 | 2023-11-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 416.4K | +0.7% | +$3,180 |
| D | 2023-10-30 | 2023-10-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 421.8K | +0.7% | +$3,180 |
| D | 2023-10-30 | 2023-10-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $5.63 | -3,000 | 418.8K | -0.7% | -$16.9K |
| D | 2023-10-02 | 2023-09-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.72 | -3,000 | 418.8K | -0.7% | -$23.2K |
| D | 2023-10-02 | 2023-09-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 421.8K | +0.7% | +$3,180 |
| DM | 2023-08-28 | 2023-08-24 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $8.66 | -3,000 | 418.8K | -0.7% | -$26.0K |
| D | 2023-08-28 | 2023-08-24 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 421.8K | +0.7% | +$3,180 |
| 2023-08-17 | 2023-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $9.18 | -5,378 | 418.8K | -1% | -$49.4K | |
| DM | 2023-07-28 | 2023-07-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $13.63 | -8,000 | 424.2K | -2% | -$109.0K |
| D | 2023-07-28 | 2023-07-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 432.2K | +2% | +$8,480 |
| D | 2023-07-03 | 2023-06-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.49 | -3,000 | 424.2K | -0.7% | -$22.5K |
| D | 2023-07-03 | 2023-06-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 427.2K | +0.7% | +$3,180 |
| D | 2023-06-02 | 2023-05-31 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $8.63 | -3,000 | 424.2K | -0.7% | -$25.9K |
| D | 2023-06-02 | 2023-05-31 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 427.2K | +0.7% | +$3,180 |
| 2023-05-17 | 2023-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $5.60 | -5,415 | 422.4K | -1% | -$30.3K | |
| D | 2023-02-27 | 2023-02-23 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.82 | -8,000 | 427.8K | -2% | -$62.6K |
| D | 2023-02-27 | 2023-02-23 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 435.8K | +2% | +$8,480 |
| 2023-02-17 | 2023-02-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $8.44 | -1,603 | 427.8K | -0.4% | -$13.5K | |
| DM | 2023-02-03 | 2023-02-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | A - Grant | $0.00 | +226.8K | 422.8K | +116% | $0 |
| D | 2023-02-03 | 2023-02-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $8.55 | -3,093 | 429.4K | -0.7% | -$26.4K |
| D | 2023-01-27 | 2023-01-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $8.07 | -8,000 | 203.7K | -4% | -$64.6K |
| D | 2023-01-27 | 2023-01-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 211.7K | +4% | +$8,480 |
| D | 2022-12-30 | 2022-12-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.70 | -8,000 | 203.7K | -4% | -$61.6K |
| D | 2022-12-30 | 2022-12-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 211.7K | +4% | +$8,480 |
| D | 2022-11-17 | 2022-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $11.86 | -1,453 | 203.7K | -0.7% | -$17.2K |
| D | 2022-11-17 | 2022-11-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +16.0K | 219.7K | +8% | +$17.0K |
| D | 2022-11-17 | 2022-11-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.96 | -16.0K | 203.7K | -7% | -$175.4K |
| D | 2022-10-28 | 2022-10-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.72 | -16.0K | 205.1K | -7% | -$171.5K |
| D | 2022-10-28 | 2022-10-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +16.0K | 221.1K | +8% | +$17.0K |
| D | 2022-10-03 | 2022-09-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +16.0K | 221.1K | +8% | +$17.0K |
| DM | 2022-10-03 | 2022-09-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.86 | -16.0K | 205.1K | -7% | -$173.8K |
| D | 2022-08-17 | 2022-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $12.96 | -1,453 | 205.1K | -0.7% | -$18.8K |
| D | 2022-08-17 | 2022-08-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +16.0K | 221.1K | +8% | +$17.0K |
| D | 2022-08-17 | 2022-08-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale+OE | $12.60 | -16.0K | 295.1K | -5% | -$201.6K |
| 2022-05-18 | 2022-05-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $5.67 | -1,458 | 206.6K | -0.7% | -$8,267 | |
| D | 2022-03-08 | 2022-03-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +58.5K | 208.0K | +39% | +$62.0K |
| D | 2022-02-22 | 2022-02-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +16.0K | 149.5K | +12% | +$17.0K |
| D | 2022-02-17 | 2022-02-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +4,000 | 133.5K | +3% | +$4,240 |
| DM | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | A - Grant | $0.00 | +82.0K | 130.3K | +170% | $0 |
| D | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | F - Tax | $11.40 | -828 | 129.5K | -0.6% | -$9,439 |
| M | 2021-12-20 | 2021-12-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale | $18.74 | -2,500 | 48.8K | -5% | -$46.9K |
| M | 2021-11-22 | 2021-11-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott | Pres, COO | S - Sale | $18.92 | -2,500 | 50.0K | -5% | -$47.3K |
Purchase Sale Sale after option exercise All abbreviations